Journal ArticleDOI
Dépistage de l’hypertension artérielle pulmonaire au cours de la sclérodermie systémique : comparaison de l’algorithme DETECT à une discussion pluridisciplinaire en centre de compétence
V. Coirier,Alain Lescoat,M. Fournet,Claire Cazalets,Guillaume Coiffier,Stéphane Jouneau,C. Chabanne,Patrick Jego +7 more
Reads0
Chats0
TLDR
L’application de l’algorithme DETECT a permis de depister toutes les HTAP diagnostiquees suite a the reunion of the concertation pluridisciplinaire.Abstract:
Resume Introduction L’hypertension arterielle pulmonaire (HTAP) est une complication grave de la sclerodermie systemique (SSc), importante a depister L’etude DETECT a propose en 2013 un algorithme de depistage Nous avons compare les indications au catheterisme cardiaque droit posees par cet algorithme, a celles retenues par une reunion de concertation pluridisciplinaire en centre de competences Patients et methodes Etude prospective monocentrique non interventionnelle ayant inclus les patients suivis pour SSc, pour qui les donnees etaient suffisantes pour appliquer l’algorithme DETECT Nous avons calcule l’algorithme et compare ses indications a la realisation d’un catheterisme cardiaque droit avec celles retenues dans notre centre suite a une reunion de concertation pluridisciplinaire Resultats Au total, 117 patients ont ete inclus En appliquant l’algorithme a l’ensemble de la population, l’indication du catheterisme etait retenue pour 70 d’entre eux ; la reunion de concertation pluridisciplinaire avait egalement retenu cette indication pour 15 d’entre eux dont 7 avaient finalement une HTAP En appliquant l’algorithme aux patients ayant une DLCO Conclusion L’application de l’algorithme DETECT a permis de depister toutes les HTAP diagnostiquees suite a la reunion de concertation pluridisciplinaire Cependant, il multiplie par trois le nombre de catheterisme cardiaque droit a realiserread more
Citations
More filters
Journal ArticleDOI
French recommendations for the management of systemic sclerosis.
Eric Hachulla,Christian Agard,Yannick Allanore,Jérôme Avouac,Brigitte Bader-Meunier,Alexandre Belot,Alice Bérezné,Anne-Sophie Bouthors,Geraldine Condette-Wojtasik,Joël Constans,Pascal de Groote,Elisabeth Diot,Florence Dumas,Patrick Jego,Francisca Joly,David Launay,Véronique Le Guern,Janine-Sophie Le Quintrec,Géraldine Lescaille,Christophe Meune,Bruno Moulin,Christelle Nguyen,Nadine Omeish,Frédéric Pène,Marie-Aleth Richard,Juliette Rochefort,Alexandra Roren,Olivier Sitbon,Vincent Sobanski,Marie-Elise Truchetet,Luc Mouthon +30 more
TL;DR: There are two main phenotypical forms of SSc: a diffuse cutaneous form that extends towards the proximal region of the limbs and/or torso, and a limited cutaneous forms where the cutaneous sclerosis only affects the extremities of the limb without passing beyond the elbows and knees as discussed by the authors.
Journal ArticleDOI
The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysis
TL;DR: The present study aimed to assess the prevalence and incidence rate of pulmonary arterial hypertension (PAH) in Systemic Sclerosis (SSc) in MEDLINE and SCOPUS from June 1962 to May 2019 and the terms: ("Scleroderma, Systemic"[MesH]) AND "Hypertension, Pulmonary"[MESH].
Journal ArticleDOI
Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes
TL;DR: In this article, a systematic review of the evidence for screening for pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (scleroderma, SSc) is presented.
Journal ArticleDOI
Screening for pulmonary arterial hypertension in systemic sclerosis: Now or never!
TL;DR: The current clinical and research implications of the screening for the early detection of SSc-PAH are addressed and best practice recommendations are for asymptomatic patients with SSc and S Sc-spectrum disorder to be screened annually.
References
More filters
Journal ArticleDOI
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Nazzareno Galiè,Marc Humbert,Jean-Luc Vachiery,Simon Gibbs,Irene Lang,Adam Torbicki,Gérald Simonneau,Andrew Peacock,Anton Vonk Noordegraaf,Maurice Beghetti,Ardeschir Ghofrani,Miguel Angel Gomez Sanchez,Georg Hansmann,Walter Klepetko,Patrizio Lancellotti,Marco Matucci,Theresa McDonagh,Luc Pierard,Pedro T. Trindade,Maurizio Zompatori,Marius M. Hoeper +20 more
TL;DR: In this paper, the authors defined the following terms: ALAT, alanine aminotransferase, ASAT, aspartate AMINOTE, and APAH, associated pulmonary arterial hypertension.
Journal ArticleDOI
2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative
Frank H J van den Hoogen,Dinesh Khanna,Jaap Fransen,Sindhu R Johnson,Murray Baron,Alan Tyndall,Marco Matucci-Cerinic,Raymond P. Naden,Thomas A. Medsger,Patricia Carreira,Gabriela Riemekasten,Philip J. Clements,Christopher P. Denton,Oliver Distler,Yannick Allanore,Daniel E. Furst,Armando Gabrielli,Maureen D. Mayes,Jacob M van Laar,James R. Seibold,László Czirják,Virginia D. Steen,Murat Inanc,Otylia Kowal-Bielecka,Ulf Müller-Ladner,Gabriele Valentini,Douglas J. Veale,Madelon C. Vonk,Ulrich A Walker,Lorinda Chung,David H. Collier,David H. Collier,Mary Ellen Csuka,Barri J. Fessler,Serena Guiducci,Ariane L. Herrick,Vivien Hsu,Sergio A. Jimenez,Bashar Kahaleh,Bashar Kahaleh,Peter A. Merkel,Stanislav Sierakowski,Richard M. Silver,Robert W. Simms,Robert W. Simms,John Varga,Janet E. Pope +46 more
TL;DR: The ACR/EULAR classification criteria for SSc performed better than the 1980 ACR criteria and should allow for more patients to be classified correctly as having the disease.
Journal ArticleDOI
Special article2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
Nazzareno Galiè,Marc Humbert,Jean-Luc Vachiery,Simon Gibbs,Irene Lang,Adam Torbicki,Gérald Simonneau,Andrew J. Peacock,Anton Vonk Noordegraaf,Maurice Beghetti,Ardeschir Ghofrani,Miguel Angel Gomez Sanchez,Georg Hansmann,Walter Klepetko,Patrizio Lancellotti,Marco Matucci,Theresa McDonagh,Luc Pierard,Marius M. Hoeper +18 more
TL;DR: This article is being published concurrently in the European Heart Journal and the European Respiratory Journal and is identical except for minor stylistic and spelling differences in keeping with each journal’s style.
Journal ArticleDOI
[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].
Nazzareno Galiè,Marc Humbert,Jean-Luc Vachiery,Simon Gibbs,Irene Lang,Adam Torbicki,Gérald Simonneau,Andrew J. Peacock,Anton Vonk Noordegraaf,Maurice Beghetti,Ardeschir Ghofrani,Miguel Angel Gomez Sanchez,Georg Hansmann,Walter Klepetko,Patrizio Lancellotti,Marco Matucci,Theresa McDonagh,Luc Pierard,Pedro T. Trindade,Maurizio Zompatori,Marius M. Hoeper +20 more
TL;DR: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) is constituted.
Journal ArticleDOI
Changes in causes of death in systemic sclerosis, 1972-2002.
TL;DR: The change in the pattern of scleroderma-related deaths over the past 30 years demonstrates that the lung (both pulmonary hypertension and PF) is the primary cause of sclerosis- related deaths today.